Tenaya Therapeutics (TNYA) Other Non-Current Liabilities (2020 - 2026)
Tenaya Therapeutics' quarterly Other Non-Current Liabilities came in at $418000.0 in Q1 2026, up 45.64% year-on-year from $287000.0 in Q1 2025, and up 1.95% quarter-over-quarter from $410000.0 in Q4 2025.
Tenaya Therapeutics has reported Other Non-Current Liabilities for 7 years, with the latest figure at $418000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 45.64% year-over-year to $418000.0; the trailing twelve-month figure through Mar 2026 stood at $418000.0 (up 45.64% YoY), and the FY2025 full-year result was $410000.0, up 45.91% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $418000.0, up from $410000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $418000.0 in Q1 2026, with the low at $212000.0 in Q1 2022.
- Average Other Non-Current Liabilities over 5 years is $273176.5, with a median of $259000.0 recorded in 2024.
- Year-over-year, Other Non-Current Liabilities soared 7133.33% in 2022 and increased 9.06% in 2025.
- Tracing TNYA's Other Non-Current Liabilities over 5 years: stood at $228000.0 in 2022, then rose by 10.96% to $253000.0 in 2023, then grew by 11.07% to $281000.0 in 2024, then jumped by 45.91% to $410000.0 in 2025, then rose by 1.95% to $418000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $418000.0 (Q1 2026), $410000.0 (Q4 2025), and $301000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 418,000.00 |
| Dec 31, 2025 | 410,000.00 |
| Sep 30, 2025 | 301,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Mar 31, 2025 | 287,000.00 |
| Dec 31, 2024 | 281,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Jun 30, 2024 | 266,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Dec 31, 2023 | 253,000.00 |
| Sep 30, 2023 | 246,000.00 |
| Jun 30, 2023 | 240,000.00 |
| Mar 31, 2023 | 234,000.00 |
| Dec 31, 2022 | 228,000.00 |
| Sep 30, 2022 | 223,000.00 |
| Jun 30, 2022 | 217,000.00 |
| Mar 31, 2022 | 212,000.00 |
| Dec 31, 2021 | 182,000.00 |
| Sep 30, 2021 | 96,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Dec 31, 2020 | 19,000.00 |